Pharmacosmos

Pharmacosmos Therapeutics Inc. is a United States specialty pharmaceutical company and the American affiliate of Denmark-based Pharmacosmos, a family-owned international healthcare company founded in 1965. The company specializes in the treatment of iron deficiency and iron deficiency anemia, focusing primarily on the prescription iron pharmaceutic... al market which represents two-thirds of its revenue. Pharmacosmos Therapeutics commercializes Monoferric, a high-dose intravenous iron treatment marketed in the United States, and provides exceptional resources to support patient care. The parent company Pharmacosmos is recognized as a global pioneer in carbohydrate chemistry and a world leader in iron therapy, with corporate headquarters, manufacturing facilities, and research laboratories located in Holbaek, Denmark. The company develops, manufactures, and markets medicines for treating iron deficiency anemia in humans and animals, while also specializing in developing and producing advanced pharmaceutical-grade carbohydrates and active pharmaceutical ingredients. Pharmacosmos maintains its own marketing, sales, and service operations in multiple countries including the United States, United Kingdom, Ireland, Germany, Sweden, Norway, and China, with representation in over 40 countries worldwide through partnerships.Read More